Dividend Yield: 3.43%
Is the dividend yield high or low?
The dividend yield of 3.43% is 21% below its 5-year average of 4.32%, near the low end of its 5-year range (2.79%–7.06%).
As of Saturday, June 27, 2026. 5.04% below its 12-month average of 3.61%.
Dividend Yield (3.43%) = TTM Dividends/Share ($1.80) / Share Price ($52.50)
GSK Dividend Yield Chart
GSK Average Dividend Yield Chart
GSK Current vs Average Dividend Yield Chart
GSK Dividend Yield Metrics
DIVIDEND YIELD
3.43%
DIVIDEND YIELD AVG TTM
3.61%
DIVIDEND YIELD AVG 3Y
3.79%
DIVIDEND YIELD AVG 5Y
4.31%
DIVIDEND YIELD AVG 10Y
4.88%
DIVIDEND YIELD AVG 15Y
5.02%
DIVIDEND YIELD AVG 20Y
4.93%
CURRENT VS TTM AVG
-5.04%
CURRENT VS 3Y AVG
-9.43%
CURRENT VS 5Y AVG
-20.41%
CURRENT VS 10Y AVG
-29.68%
CURRENT VS 15Y AVG
-31.62%
CURRENT VS 20Y AVG
-30.45%
GSK Competitors' Dividend Yield
| NAME | MARKET CAP | DIVIDEND YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GSK plc (GSK) | $105.20B | 3.43% | 3.61% | 3.79% | 4.31% |
| Medtronic plc (MDT)vs › | $103.66B | 3.56% | 3.11% | 3.26% | 3.06% |
| Bristol-Myers Squibb Company (BMY)vs › | $117.46B | 4.38% | 4.73% | 4.67% | 3.97% |
| McKesson Corporation (MCK)vs › | $89.39B | 0.43% | 0.38% | 0.46% | 0.55% |
| HCA Healthcare, Inc. (HCA)vs › | $86.89B | 0.80% | 0.66% | 0.78% | 0.84% |
| Elevance Health Inc. (ELV)vs › | $85.82B | 1.74% | 2.02% | 1.62% | 1.42% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $124.70B | N/A | N/A | N/A | N/A |
| Stryker Corporation (SYK)vs › | $127.39B | 1.06% | 0.72% | 0.88% | 0.98% |
| CVS Health Corp. (CVS)vs › | $133.13B | 2.55% | 3.41% | 3.83% | 3.28% |
| Cigna Corporation (CI)vs › | $74.81B | 2.21% | 2.12% | 1.89% | 1.79% |
Dividend Yield Formula & Definition
Dividend yield is the trailing-12-month dividends per share divided by the share price — the cash income the stock pays at today's price. A yield far above a company's own history can signal either value or a market doubting the dividend; read it with the payout ratio.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Dividend Yield FAQ
- What is the dividend yield for GSK plc (GSK)?
- The dividend yield for GSK stock is 3.43%.
- Is GSK plc's dividend yield high or low?
- The dividend yield of 3.43% is 21% below its 5-year average of 4.32%, near the low end of its 5-year range (2.79%–7.06%).
- What is the TTM average dividend yield for GSK plc (GSK)?
- The TTM average dividend yield for GSK stock is 3.61%.
- What is the 3Y average dividend yield for GSK plc (GSK)?
- The 3Y average dividend yield for GSK stock is 3.79%.
- What is the 5Y average dividend yield for GSK plc (GSK)?
- The 5Y average dividend yield for GSK stock is 4.31%.
- What is the 10Y average dividend yield for GSK plc (GSK)?
- The 10Y average dividend yield for GSK stock is 4.88%.
- What is the 15Y average dividend yield for GSK plc (GSK)?
- The 15Y average dividend yield for GSK stock is 5.02%.
- What is the 20Y average dividend yield for GSK plc (GSK)?
- The 20Y average dividend yield for GSK stock is 4.93%.
GSK Dividend Yield History
| DATE | DIVIDEND YIELD |
|---|---|
| 2026-06-26 | 3.43% |
| 2026-06-24 | 3.53% |
| 2026-06-22 | 3.55% |
| 2026-06-17 | 3.45% |
| 2026-06-15 | 3.45% |
| 2026-06-11 | 3.41% |
| 2026-06-09 | 3.52% |
| 2026-06-05 | 3.50% |
| 2026-06-03 | 3.62% |
| 2026-06-01 | 3.65% |
| 2026-05-28 | 3.52% |
| 2026-05-26 | 3.50% |
| 2026-05-21 | 3.50% |
| 2026-05-19 | 3.53% |
| 2026-05-15 | 4.50% |
| 2026-05-13 | 3.48% |
| 2026-05-11 | 3.56% |
| 2026-05-07 | 3.52% |
| 2026-05-05 | 3.52% |
| 2026-05-01 | 3.44% |
| 2026-04-29 | 3.45% |
| 2026-04-27 | 3.27% |
| 2026-04-23 | 3.19% |
| 2026-04-21 | 3.16% |
| 2026-04-17 | 3.04% |
| 2026-04-15 | 3.07% |
| 2026-04-13 | 3.01% |
| 2026-04-09 | 3.04% |
| 2026-04-07 | 3.18% |
| 2026-04-02 | 3.13% |
| 2026-03-31 | 3.22% |
| 2026-03-27 | 3.30% |
| 2026-03-25 | 3.25% |
| 2026-03-23 | 3.41% |
| 2026-03-19 | 3.39% |
| 2026-03-17 | 3.32% |
| 2026-03-13 | 3.33% |
| 2026-03-11 | 3.22% |
| 2026-03-09 | 3.20% |
| 2026-03-05 | 3.21% |
| 2026-03-03 | 3.11% |
| 2026-02-27 | 3.00% |
| 2026-02-25 | 2.98% |
| 2026-02-23 | 3.00% |
| 2026-02-19 | 2.79% |
| 2026-02-17 | 2.79% |
| 2026-02-12 | 2.90% |
| 2026-02-10 | 2.89% |
| 2026-02-06 | 2.82% |
| 2026-02-04 | 2.97% |
| 2026-02-02 | 3.24% |
| 2026-01-29 | 3.35% |
| 2026-01-27 | 3.34% |
| 2026-01-23 | 3.46% |
| 2026-01-21 | 3.53% |
| 2026-01-16 | 3.52% |
| 2026-01-14 | 3.34% |
| 2026-01-12 | 3.37% |
| 2026-01-08 | 3.38% |
| 2026-01-06 | 3.36% |
| 2026-01-02 | 3.42% |
| 2025-12-30 | 3.45% |
| 2025-12-26 | 3.46% |
| 2025-12-23 | 3.48% |
| 2025-12-19 | 3.49% |
| 2025-12-17 | 3.49% |
| 2025-12-15 | 3.45% |
| 2025-12-11 | 3.47% |
| 2025-12-09 | 3.59% |
| 2025-12-05 | 3.51% |
| 2025-12-03 | 3.47% |
| 2025-12-01 | 3.60% |
| 2025-11-26 | 3.54% |
| 2025-11-24 | 3.61% |
| 2025-11-20 | 3.68% |
| 2025-11-18 | 3.59% |
| 2025-11-14 | 4.42% |
| 2025-11-12 | 3.44% |
| 2025-11-10 | 3.49% |
| 2025-11-06 | 3.51% |
| 2025-11-04 | 3.53% |
| 2025-10-31 | 3.53% |
| 2025-10-29 | 3.60% |
| 2025-10-27 | 3.78% |
| 2025-10-23 | 3.63% |
| 2025-10-21 | 3.77% |
| 2025-10-17 | 3.77% |
| 2025-10-15 | 3.78% |
| 2025-10-13 | 3.79% |
| 2025-10-09 | 3.81% |
| 2025-10-07 | 3.80% |
| 2025-10-03 | 3.82% |
| 2025-10-01 | 3.64% |
| 2025-09-29 | 4.03% |
| 2025-09-25 | 4.19% |
| 2025-09-23 | 4.08% |
| 2025-09-19 | 4.07% |
| 2025-09-17 | 4.10% |
| 2025-09-15 | 4.11% |
| 2025-09-11 | 3.99% |
| 2025-09-09 | 4.06% |
| 2025-09-05 | 4.09% |
| 2025-09-03 | 4.20% |
| 2025-08-29 | 4.17% |
| 2025-08-27 | 4.15% |
| 2025-08-25 | 4.17% |
| 2025-08-21 | 4.13% |
| 2025-08-19 | 4.18% |
| 2025-08-15 | 5.18% |
| 2025-08-13 | 4.11% |
| 2025-08-11 | 4.27% |
| 2025-08-07 | 4.28% |
| 2025-08-05 | 4.31% |
| 2025-08-01 | 4.29% |
| 2025-07-30 | 4.13% |
| 2025-07-28 | 4.30% |
| 2025-07-24 | 4.21% |
| 2025-07-22 | 4.35% |
| 2025-07-18 | 4.43% |
| 2025-07-16 | 4.21% |
| 2025-07-14 | 4.21% |
| 2025-07-10 | 4.07% |
| 2025-07-08 | 4.18% |
| 2025-07-03 | 4.22% |
| 2025-07-01 | 4.13% |
| 2025-06-27 | 4.17% |
| 2025-06-25 | 4.21% |
| 2025-06-23 | 4.21% |
| 2025-06-18 | 4.17% |
| 2025-06-16 | 3.98% |
| 2025-06-12 | 3.79% |
| 2025-06-10 | 3.90% |
| 2025-06-06 | 3.91% |
| 2025-06-04 | 3.95% |
| 2025-06-02 | 3.86% |
| 2025-05-29 | 4.03% |
| 2025-05-27 | 4.08% |
| 2025-05-22 | 4.14% |
| 2025-05-20 | 4.19% |
| 2025-05-16 | 4.28% |
| 2025-05-14 | 4.28% |
| 2025-05-12 | 4.15% |
| 2025-05-08 | 4.21% |
| 2025-05-06 | 4.14% |
| 2025-05-02 | 3.97% |
| 2025-04-30 | 3.89% |
| 2025-04-28 | 4.08% |
| 2025-04-24 | 4.14% |
| 2025-04-22 | 4.24% |
| 2025-04-17 | 4.32% |
| 2025-04-15 | 4.35% |
| 2025-04-11 | 4.48% |
| 2025-04-09 | 4.50% |
| 2025-04-07 | 4.45% |
| 2025-04-03 | 3.98% |
| 2025-04-01 | 4.10% |
| 2025-03-28 | 4.01% |
| 2025-03-26 | 4.05% |
| 2025-03-24 | 4.02% |
| 2025-03-20 | 3.94% |
| 2025-03-18 | 3.84% |
| 2025-03-14 | 3.93% |
| 2025-03-12 | 3.99% |
| 2025-03-10 | 3.85% |
| 2025-03-06 | 3.95% |
| 2025-03-04 | 4.04% |
| 2025-02-28 | 4.13% |
| 2025-02-26 | 4.15% |
| 2025-02-24 | 4.18% |
| 2025-02-20 | 4.21% |
| 2025-02-18 | 4.25% |
| 2025-02-13 | 4.26% |
| 2025-02-11 | 4.32% |
| 2025-02-07 | 4.32% |
| 2025-02-05 | 4.13% |
| 2025-02-03 | 4.46% |
| 2025-01-30 | 4.40% |
| 2025-01-28 | 4.44% |
| 2025-01-24 | 4.54% |
| 2025-01-22 | 4.66% |
| 2025-01-17 | 4.66% |
| 2025-01-15 | 4.75% |
| 2025-01-13 | 4.76% |
| 2025-01-08 | 4.61% |
| 2025-01-06 | 4.58% |
| 2025-01-02 | 4.59% |
| 2024-12-30 | 4.63% |
| 2024-12-26 | 4.56% |
| 2024-12-23 | 4.57% |
| 2024-12-19 | 4.66% |
| 2024-12-17 | 4.55% |
| 2024-12-13 | 4.59% |
| 2024-12-11 | 4.52% |
| 2024-12-09 | 4.33% |
| 2024-12-05 | 4.51% |
| 2024-12-03 | 4.46% |
| 2024-11-29 | 4.56% |
| 2024-11-26 | 4.58% |
| 2024-11-22 | 4.58% |
| 2024-11-20 | 4.67% |
| 2024-11-18 | 4.62% |
| 2024-11-14 | 4.38% |
| 2024-11-12 | 4.24% |
| 2024-11-08 | 4.15% |
| 2024-11-06 | 4.20% |
| 2024-11-04 | 4.08% |
| 2024-10-31 | 4.10% |
| 2024-10-29 | 3.95% |
| 2024-10-25 | 4.02% |
| 2024-10-23 | 3.97% |
| 2024-10-21 | 3.95% |
| 2024-10-17 | 3.87% |
| 2024-10-15 | 3.87% |
| 2024-10-11 | 3.88% |
| 2024-10-09 | 3.75% |
| 2024-10-07 | 3.90% |
| 2024-10-03 | 3.93% |
| 2024-10-01 | 3.74% |
| 2024-09-27 | 3.70% |
| 2024-09-25 | 3.72% |
| 2024-09-23 | 3.69% |
| 2024-09-19 | 3.62% |
| 2024-09-17 | 3.54% |
| 2024-09-13 | 3.51% |
| 2024-09-11 | 3.44% |
| 2024-09-09 | 3.43% |
| 2024-09-05 | 3.50% |
| 2024-09-03 | 3.47% |
| 2024-08-29 | 3.45% |
| 2024-08-27 | 3.41% |
| 2024-08-23 | 3.54% |
| 2024-08-21 | 3.60% |
| 2024-08-19 | 3.63% |
| 2024-08-15 | 3.58% |
| 2024-08-13 | 3.60% |
| 2024-08-09 | 3.68% |
| 2024-08-07 | 3.77% |
| 2024-08-05 | 3.77% |
| 2024-08-01 | 3.74% |
| 2024-07-30 | 3.73% |
| 2024-07-26 | 3.72% |
| 2024-07-24 | 3.77% |
| 2024-07-22 | 3.77% |
| 2024-07-18 | 3.77% |
| 2024-07-16 | 3.81% |
| 2024-07-12 | 3.79% |
| 2024-07-10 | 3.85% |
| 2024-07-08 | 3.83% |
| 2024-07-03 | 3.86% |
| 2024-07-01 | 3.86% |
| 2024-06-27 | 3.84% |
| 2024-06-25 | 3.68% |
| 2024-06-21 | 3.66% |
| 2024-06-18 | 3.62% |
| 2024-06-14 | 3.65% |
| 2024-06-12 | 3.61% |
| 2024-06-10 | 3.59% |
| 2024-06-06 | 3.57% |
| 2024-06-04 | 3.59% |
| 2024-05-31 | 3.31% |
Showing the most recent 260 of 3,771 data points. The chart above shows the full history.
About GSK plc
GSK plc, a global pharmaceutical entity founded in 1715 and headquartered in Brentford, United Kingdom, dedicates its efforts to the research, development, and manufacturing of a wide array of medical solutions. Until May 2022, the company was known as GlaxoSmithKline plc. Its primary objective is to prevent and treat illnesses by producing both vaccines and a comprehensive range of specialty and general medicines for markets across the United Kingdom, the United States, and internationally. The company's operations are organized into two key divisions: Commercial Operations and Total R&D. Its extensive vaccine portfolio includes immunizations against shingles, meningitis, respiratory syncytial virus (RSV), seasonal and pandemic influenza, and polio. Beyond preventative care, GSK provides diverse therapeutic products covering critical areas such as HIV, oncology, respiratory and immunology conditions, and other specialized medical fields. This also encompasses inhaled treatments for chronic respiratory ailments like asthma and chronic obstructive pulmonary disease (COPD), along with antibiotics for various infections. Innovation at GSK is frequently driven by strategic partnerships. Notable collaborations include an agreement with CureVac to advance mRNA-based influenza vaccines, and alliances with Wave Life Sciences and Elsie Biotechnologies focused on developing oligonucleotide platforms. Furthermore, GSK has established two distinct strategic collaborations with Relation to progress therapeutics for fibrotic diseases and osteoarthritis. The company is also engaged in a multi-target strategic alliance aimed at developing pioneering treatments for individuals suffering from Parkinson's disease, and a partnership with Flagship Pioneering to identify novel medicines and vaccines.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Luke Victor Miels